Glucose transporter

Beta-D-Glucose

Glucose transporters are a wide group of membrane proteins that facilitate the transport of glucose across the plasma membrane of cells. They play a critical role in maintaining glucose homeostasis in the body, enabling the uptake of glucose by tissues for metabolism and energy production. There are several types of glucose transporters, classified into two main families: the Sodium-glucose transport proteins (SGLTs) and the Facilitated glucose transporters (GLUTs).

Types of Glucose Transporters

Sodium-glucose transport proteins (SGLTs)

SGLTs are responsible for the active transport of glucose against its concentration gradient. This process requires energy, which is obtained from the sodium gradient across the membrane. SGLTs are primarily found in the kidney and intestinal epithelial cells, where they play a significant role in glucose reabsorption from the urine and glucose absorption from the diet, respectively.

Facilitated glucose transporters (GLUTs)

GLUTs facilitate the passive transport of glucose across cell membranes, down its concentration gradient. This process does not require energy. There are several types of GLUTs, each with a specific distribution and function in the body. For example, GLUT1 is widely distributed and is responsible for the basal uptake of glucose into cells, while GLUT4 is found in adipose tissue and muscle and is regulated by insulin.

Function and Regulation

Glucose transporters are essential for the regulation of glucose levels in the blood. In response to varying levels of glucose and insulin, these transporters adjust the rate of glucose uptake by cells. For instance, in the postprandial state (after eating), insulin levels rise, leading to an increase in GLUT4 transporters on the surface of muscle and adipose cells, thereby increasing glucose uptake and reducing blood glucose levels.

Clinical Significance

Abnormalities in glucose transporter function can lead to several metabolic disorders. For example, a deficiency in GLUT1 can cause Glucose Transporter Type 1 Deficiency Syndrome (GLUT1DS), a rare neurological disorder characterized by seizures, developmental delay, and movement disorders. Furthermore, alterations in the expression and function of GLUT4 are associated with insulin resistance and type 2 diabetes.

Research and Therapeutic Applications

Research on glucose transporters has led to the development of therapeutic strategies for managing diabetes and other metabolic diseases. For instance, inhibitors of SGLT2 are used as medications to lower blood glucose levels in people with type 2 diabetes by promoting the excretion of glucose in the urine.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian